Hikma Gets FDA Warning After Portugal Facility Review
Hikma Pharmaceuticals PLC has received a warning letter from the U.S. Food and Drug Administration, which inspected the Jordan-based drugmaker's manufacturing facility in Portugal earlier this year, the company said Friday. ...To view the full article, register now.
Already a subscriber? Click here to view full article